Clinical Trial Update: Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated Circadin (melatonin) in children with neurodevelopmental disorders and sleep disturbances and has completed. The fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders
• Sleep Disorders

Drugs mentioned

• Circadin (melatonin)

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Sleep Problems | Phase 1 | Status: COMPLETED